Montanide ISA 720
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Montanide ISA 720, covering 2017-07-31 to 2017-07-31. Get the full timeline:
Most recent: Clinical Trial Update: CpG 7909/Montanide ISA 720 With or Without Cyclophosphamide in Combination Either With NY-ESO-1-derived Peptides or the NY-ESO-1 Protein for NY-ESO-1-expressing Tumors [Phase 1]